RecruitingNCT06179602

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors Within the IMAGIO Project (A-IMAGIO)


Sponsor

Leiden University Medical Center

Enrollment

1,500 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The endpoint of this study is to develop and validate algorithms, using artificial intelligence and machine learning, to optimize patient selection, treatment planning, treatment evaluation and outcome prediction in patients undergoing thermal ablation of a malignant liver tumor. The long-term objective is to establish thermal ablation as the treatment of choice for the vast majority of patients with a primary or secondary liver tumor by development of an accessible workflow that can be widely implemented in different centers performing thermal ablation. Over a time span of at least four years, data will be collected prospectively, encompassing patient information, tumor characteristics, and treatment details. Additionally, pre-, intra-, and post-procedural imaging will be systematically gathered.


Eligibility

Min Age: 18 YearsMax Age: 110 Years

Inclusion Criteria3

  • years or above
  • Candidate for percutaneous thermal liver ablation as discussed in a multidisciplinary tumorboard (MDT)
  • Informed consent

Exclusion Criteria1

  • Patients lacking capacity to give informed consent.

Locations(1)

Leiden University Medical Centre

Leiden, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06179602


Related Trials